Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Scientific Reports|February 19, 2022
A model to quantify the influence of treatment patterns and optimize outcomes in nAMDFocke Ziemssen, Hansjürgen Agostini, Nicolas Feltgen, et al.
NPJ Primary Care Respiratory Medicine|October 30, 2019
Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort studyDavid B Price, Jaco Voorham, Guy Brusselle, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 16, 2016
Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING)Jose M Marin, Kai M Beeh, Andreas Clemens, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|March 28, 2022
Brolucizumab 12- and 16-Week Fixed Dosing Potential in Neovascular AMD: A post hoc Evaluation of Data from the HAWK and HARRIER TrialsMichael Singer, Arshad M Khanani, Armin Wolf, et al.
The British Journal of Ophthalmology|August 7, 2021
Does real-time artificial intelligence-based visual pathology enhancement of three-dimensional optical coherence tomography scans optimise treatment decision in patients with nAMD? Rationale and design of the RAZORBILL studyFrank G Holz, Rodrigo Abreu-Gonzalez, Francesco Bandello, et al.
Primary Care Diabetes|July 9, 2016
Patient engagement impacts glycemic management with vildagliptin and vildagliptin/metformin (single pill) regimens in type 2 diabetes mellitus (the GLORIOUS study)Michel Hermans, Luc Van Gaal, Ingrid Rézette, et al.
Circulation|August 7, 2016
Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy)Michael D Ezekowitz, Rangadham Nagarakanti, Herbert Noack, et al.
ERJ Open Research|March 1, 2019
Treatment response in COPD: does FEV1 say it all? A post hoc analysis of the CRYSTAL studyKonstantinos Kostikas, Timm Greulich, Alexander J Mackay, et al.
International Journal of Cardiology|June 21, 2015
Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trialMichela Brambatti, Harald Darius, Jonas Oldgren, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 2, 2018
Indacaterol/glycopyrronium reduces the risk of clinically important deterioration after direct switch from baseline therapies in patients with moderate COPD: a post hoc analysis of the CRYSTAL studyTimm Greulich, Konstantinos Kostikas, Mina Gaga, et al.
Pageof 9